Galectin Therapeutics (GALT) halted, news pending
- Oil edges up ahead of U.S. data, OPEC squabbles cap gains
- DuPont (DD) Tops Q3 EPS by 14c; Boosts FY16 EPS Outlook; Says Continuing to Work with Regulators
- Visa (V) Tops Q4 EPS by 5c
- Rambus (RMBS) Tops Q3 EPS by 3c; Issues Q4 Outlook
- After-Hours Stock Movers 10/24: (SAEX) (CWEI) (RMBS) Higher; (SONC) (WNC) (EFII) Lower (more...)
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Galectin Therapeutics (NASDAQ: GALT) halted, news pending
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pluristem Therapeutics (PSTI) Enters $30M Equity Investment Agreement with China's Innovative Medical
- Equity and Commodity Markets
- Stocks with Implied Volatility Movement
Create E-mail Alert Related CategoriesTrader Talk, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!